Canopy Growth shrinks loss as medical cannabis, vaporizer sales rise

https://s43720.pcdn.co/wp-content/uploads/2024/05/canopy-growth-brands-as-of-may-2024-min.png

Canopy Growth Corp. (TSX: WEED) (Nasdaq: CGC) posted a net loss of C$121.9 million in its fiscal third quarter, a 47% improvement since last year’s period, as the Canadian producer showed growth in its medical and international segments amid ongoing restructuring efforts.

The Ontario-based company reported revenue of C$74.8 million, coming…

Please login to read all 206 words.

Leave a Reply

Your email address will not be published. Required fields are marked *